Evid Invest
Who owns CTMXWhat CTMX owns — n/a

Who owns CytomX Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CTMX from SEC Form 13F filings across 194 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 194 institutions disclosed 216.1M shares of CytomX Therapeutics, Inc. worth $587.9M — about 98.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

194

13F holders

$587.9M

value, 2026 filers

98.6%

of shares outstanding (216.1M sh)

41

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CTMX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC34.3M$93.4M0.0%15.7%+5.0%
2Kynam Capital Management, LP21.1M$57.5M3.2%9.6%-2.6%
3BlackRock, Inc.18.5M$50.2M0.0%8.4%+5.2%
4BANK OF AMERICA CORP /DE/11.6M$31.5M0.0%5.3%-23.3%
5PERCEPTIVE ADVISORS LLC9.3M$25.2M0.4%4.2%-11.2%
6STATE STREET CORP9.0M$24.6M0.0%4.1%-23.2%
7VANGUARD CAPITAL MANAGEMENT LLC8.7M$23.8M0.0%4%+2.4%
8Point72 Asset Management, L.P.8.6M$23.4M0.0%3.9%+10.2%
9CITADEL ADVISORS LLC7.0M$19.1M0.0%3.2%+125.4%
10TWO SIGMA INVESTMENTS, LP5.4M$14.6M0.0%2.5%+30.3%
11GEODE CAPITAL MANAGEMENT, LLC5.1M$13.9M0.0%2.3%+8.9%
12BAKER BROS. ADVISORS LP5.0M$13.5M0.1%2.3%0.0%
13WELLINGTON MANAGEMENT GROUP LLP4.7M$12.9M0.0%2.2%-8.5%
14Elmind Capital, LP4.5M$12.4M3.1%2.1%0.0%
15Nextech Invest Ltd.4.4M$12.1M0.5%2%0.0%
16MARSHALL WACE, LLP4.4M$11.9M0.0%2%+44.3%
17Qube Research & Technologies Ltd4.2M$11.4M0.0%1.9%+129.5%
18Eversept Partners, LP3.5M$9.6M0.5%1.6%-0.4%
19Siren, L.L.C.3.5M$9.4M0.2%1.6%0.0%
20UBS Group AG3.4M$9.3M0.0%1.6%-0.9%
21GOLDMAN SACHS GROUP INC3.2M$8.7M0.0%1.5%+59.5%
22ADAR1 Capital Management, LLC2.2M$6.0M0.3%1%-34.5%
23Woodline Partners LP2.1M$5.6M0.0%0.9%+1.1%
24VANGUARD PORTFOLIO MANAGEMENT LLC2.1M$5.6M0.0%0.9%+17.4%
25NORTHERN TRUST CORP1.7M$4.7M0.0%0.8%+4.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.